Suppr超能文献

D1和D2多巴胺受体刺激大鼠下丘脑-垂体-肾上腺活动。

D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.

作者信息

Borowsky B, Kuhn C M

机构信息

Department of Pharmacology, Duke University Medical Center, Durham, NC 27710.

出版信息

Neuropharmacology. 1992 Jul;31(7):671-8. doi: 10.1016/0028-3908(92)90145-f.

Abstract

A stimulatory role for endogenous dopamine (DA) in the regulation of hypothalamo-pituitary-adrenal activity has previously been demonstrated. In the present study, the roles of D1 and D2 subtypes of DA receptors in the regulation of activity of the hypothalamo-pituitary-adrenal axis were investigated. The intraperitoneal administration of either the D1 agonist, SKF 383393 (1-phenyl-2,3,4,5 tetrahydro-(iH)-benzazepine-7,8diol HCl, 5-20 mg/kg) or the D2 agonist quinpirole (0.05-1 mg/kg) dose-dependently elevated both adrenocorticotropic hormone (ACTH) and corticosterone (CS) in serum. Similarly, administration of either SKF 38393 or quinpirole (1-100 micrograms) into the third ventricle dose-dependently elevated ACTH in serum. The response of ACTH to intraperitoneal SKF 38393 was blocked by pretreatment with the D1 antagonist SCH 23390 (1-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5 tetrahydro-1H-3-benzazepine, 0.25 mg/kg, i.p.) but not by the D2 antagonist sulpiride (50 mg/kg, i.p.). The response of ACTH to intraperitoneal injection of quinpirole was blocked by pretreatment with sulpiride and attenuated slightly by pretreatment with SCH 23390. Further, the co-administration of sub-maximum doses of SKF 38393 and quinpirole caused additive increases in ACTH in serum. These results suggest that both D1 and D2 subtypes of DA receptors contribute to the dopaminergic regulation of function of the hypothalamo-pituitary-adrenal axis and support a role for DA neurons in the hypothalamus in this response. Further, these findings suggest that the D1 and D2 receptors, mediating the response of the hypothalamopituitary-adrenal axis are not tightly coupled.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

内源性多巴胺(DA)在调节下丘脑 - 垂体 - 肾上腺活动中的刺激作用先前已得到证实。在本研究中,研究了DA受体的D1和D2亚型在调节下丘脑 - 垂体 - 肾上腺轴活动中的作用。腹腔注射D1激动剂SKF 383393(1 - 苯基 - 2,3,4,5 - 四氢 -(1H) - 苯并氮杂卓 - 7,8 - 二醇盐酸盐,5 - 20mg / kg)或D2激动剂喹吡罗(0.05 - 1mg / kg)可使血清中促肾上腺皮质激素(ACTH)和皮质酮(CS)剂量依赖性升高。同样,向第三脑室内注射SKF 38393或喹吡罗(1 - 100微克)也可使血清中ACTH剂量依赖性升高。ACTH对腹腔注射SKF 38393的反应可被D1拮抗剂SCH 23390(1 - 氯 - 8 - 羟基 - 3 - 甲基 - 1 - 苯基 - 2,3,4,5 - 四氢 - 1H - 3 - 苯并氮杂卓,0.25mg / kg,腹腔注射)预处理阻断,但不能被D2拮抗剂舒必利(50mg / kg,腹腔注射)阻断。ACTH对腹腔注射喹吡罗的反应可被舒必利预处理阻断,并被SCH 23390预处理轻微减弱。此外,联合给予次最大剂量的SKF 38393和喹吡罗可使血清中ACTH增加。这些结果表明,DA受体的D1和D2亚型均参与多巴胺能对下丘脑 - 垂体 - 肾上腺轴功能的调节,并支持下丘脑DA神经元在此反应中的作用。此外,这些发现表明,介导下丘脑 - 垂体 - 肾上腺轴反应的D1和D2受体并非紧密偶联。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验